Search Results 31-40 of 17380 for GLP-1 medications

  1. Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in Type 1 and Type 2 Diabetes - Mayo Clinic

    ... GLP-1. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.

  2. A Study To Determine The Effects Of Blocking The Receptors Of GLP-1 On Appetite After Bariatric Surgery - Mayo Clinic

    A Study To Determine The Effects Of Blocking The Receptors Of GLP-1 On Appetite After Bariatric Surgery ... treatments, drugs, surgical procedures or devices.

  3. Effect of Tirzepatide on Physical Function in Postmenopausal Women With Obesity - Mayo Clinic

    Therefore, our overarching goal is to determine the effect of weight loss induced by the new generation of GLP-1 receptor agonists on physical function ...

  4. Use of weight-loss pharmacotherapy in patients with cirrhosis and in liver transplant recipients - Mayo Clinic

    ... 1 (GLP-1) agonists due to their additional benefits in glucose management. Guidance for using weight-loss medications.

  5. Obesity - Diagnosis and treatment - Mayo Clinic

    Also approved by the FDA is a class of drugs known as glucagonlike peptide 1 agonists, also called GLP-1 agonists. Some of these medicines are approved ...

  6. Mayo Clinic Q and A: Weight loss and genetics

    ... glucagon-like peptide-1 (GLP-1). Semaglutide medications such as Wegovy, Ozempic and Rybelsus work on behalf of the GLP-1 hormone. They connect between the ...

  7. Glucagon (nasal route) - Side effects & dosage - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. ... 1 year of age and older. However, safety and ...

  8. A Study Of GLP-1–Based Therapies On Sexual Health In Postmenopausal Women - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  9. Tradipitant After GLP-1R Agonist In Healthy, Overweight, or Class I or II Obese Volunteers - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. Islet GLP-1 in Prediabetes - Clinical Trials

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...